We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.41B
AUM Growth
+$125M
Cap. Flow
-$6.29M
Cap. Flow %
-0.45%
Top 10 Hldgs %
35.33%
Holding
276
New
13
Increased
51
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
CLF icon
Cleveland-Cliffs
CLF
+$3.71M
2
XOM icon
ExxonMobil
XOM
+$2.57M
3
PANW icon
Palo Alto Networks
PANW
+$1.41M
4
NVO
Novo Nordisk
NVO
+$1.2M
5
URI icon
United Rentals
URI
+$909K

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$3.95M
2
VZ icon
Verizon
VZ
+$2.07M
3
NEE icon
NextEra Energy
NEE
+$1.38M
4
INTC icon
Intel
INTC
+$1.28M
5
IBM icon
IBM
IBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 19.24%
3 Financials 13.15%
4 Industrials 11.27%
5 Communication Services 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
26
AbbVie
ABBV
$435B
$17M 1.21%
125,907
-990
-0.8% -$117K
UNH icon
27
UnitedHealth
UNH
$370B
$17M 1.21%
33,945
-283
-0.8% -$128K
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.13T
$16.7M 1.19%
55,987
-785
-1% -$225K
META icon
29
Meta Platforms (Facebook)
META
$1.51T
$16.3M 1.15%
48,377
+88
+0.2% +$29.2K
HON icon
30
Honeywell
HON
$78B
$15.7M 1.12%
80,117
-2,138
-3% -$432K
MRK icon
31
Merck
MRK
$318B
$15.4M 1.09%
201,444
-1,195
-0.6% -$95.2K
ON icon
32
ON Semiconductor
ON
$31.6B
$14.9M 1.06%
219,238
+4,642
+2% +$263K
J icon
33
Jacobs Solutions
J
$17B
$14.3M 1.02%
124,536
-1,047
-0.8% -$121K
PG icon
34
Procter & Gamble
PG
$339B
$14.2M 1%
86,624
-957
-1% -$142K
CRM icon
35
Salesforce
CRM
$158B
$13.1M 0.93%
51,622
+1,338
+3% +$376K
ORCL icon
36
Oracle
ORCL
$423B
$12.4M 0.88%
141,845
-2,147
-1% -$202K
PEP icon
37
PepsiCo
PEP
$190B
$10.8M 0.76%
61,995
-87
-0.1% -$14.2K
CVS icon
38
CVS Health
CVS
$122B
$9.83M 0.7%
95,285
-1,950
-2% -$180K
BXMT icon
39
Blackstone Mortgage Trust
BXMT
$2.38B
$9.81M 0.7%
320,554
-1,247
-0.4% -$39.6K
EMR icon
40
Emerson Electric
EMR
$88.3B
$9.75M 0.69%
104,900
– –
BMY icon
41
Bristol-Myers Squibb
BMY
$132B
$9.67M 0.69%
155,162
-8,950
-5% -$525K
PFE icon
42
Pfizer
PFE
$153B
$9.25M 0.66%
156,713
-2,172
-1% -$108K
LIN icon
43
Linde
LIN
$226B
$8.43M 0.6%
24,327
+320
+1% +$104K
IBB icon
44
iShares Biotechnology ETF
IBB
$9.77B
$8.16M 0.58%
53,466
-835
-2% -$129K
AXP icon
45
American Express
AXP
$230B
$8.06M 0.57%
49,277
– –
ADP icon
46
Automatic Data Processing
ADP
$108B
$7.89M 0.56%
32,007
-800
-2% -$181K
ABT icon
47
Abbott
ABT
$187B
$7.72M 0.55%
54,841
-550
-1% -$70.4K
INTC icon
48
Intel
INTC
$513B
$7.68M 0.54%
149,152
-25,100
-14% -$1.28M
CVX icon
49
Chevron
CVX
$366B
$7.46M 0.53%
63,571
+1,028
+2% +$117K
RTX icon
50
RTX Corp
RTX
$301B
$7.38M 0.52%
85,797
-900
-1% -$78.4K
1
2
3 4 5

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, Neville Rodie & Shaw held 276 positions worth $1.41B, up 9.7% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Neville Rodie & Shaw's Q4 2021 filing shows 13 new, 51 increased, 96 reduced and 8 closed positions. Its largest new stake was Cleveland-Cliffs: 172,300 shares worth $3.75M. The largest sale was Acceleron Pharma, an estimated $3.95M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q4 2021 buy was Cleveland-Cliffs: 172,300 shares worth $3.75M.
  • Neville Rodie & Shaw added most to ExxonMobil in Q4 2021, an estimated $2.57M increase.
  • Neville Rodie & Shaw's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.07M.
  • Neville Rodie & Shaw fully exited Acceleron Pharma in Q4 2021, selling an estimated $3.95M.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $1.41B portfolio in Q4 2021.
  • Neville Rodie & Shaw opened 13 new positions and closed 8 in Q4 2021.
  • Neville Rodie & Shaw's portfolio value rose 9.7% quarter-over-quarter to $1.41B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2021, filed 5 Jan 2022.